急性心肌梗死后不同剂量血管紧张素Ⅱ1型受体拮抗剂早期干预对心功能和神经激素的影响
出处
《临床荟萃》
CAS
北大核心
2008年第7期482-484,共3页
Clinical Focus
参考文献10
-
1Flather MD,Yusuf S,Kober L,et al,Long-term ACE-inhibitor therapy in patients with heart heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients[J]. Lancet,2000,355 (9215) :1575-1581.
-
2华琦,李东宝.从HOPE、EUROPA、PEACE试验评价血管紧张素转换酶抑制剂在冠心病二级预防中的作用[J].临床荟萃,2007,22(3):153-154. 被引量:3
-
3Yang YJ, Tang YD, Ruan YM, et al. Comparative effects of carvedilol and losartan alone and in combination for reventing left ventricular remodeling after acute myocardial infarction in tars[J]. Circ J,2003 ,67(2) :159-162.
-
4ACE Inhibitor Myocardial Infarction Collaborative Group.Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100, 000patients in randomized trials[J]. Circulation, 1998,97(22) :2202-2212.
-
5Kober L,Torp-Pedersen C,Carlsen JE,et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction [J]. N Engl J Med,1995,333(25) :1670-1676.
-
6张颖轩.氯沙坦治疗急性心肌梗死合并高尿酸血症患者的临床研究[J].临床荟萃,2007,22(21):1573-1574. 被引量:2
-
7de Gasparo M, Levens N. Does blockade of angiotensin Ⅱ receptors offer clinical benefits over inhibition of angiotensin- convertong enzyme? [ J ]. Pharmacol Toxicol, 1998, 82 (6) : 257-271.
-
8Urata H, Healy B, Stewart RW, et al. Angiotensin Ⅱ-forming pathways in normal and failing human hearts[J]. Circ, Res, 1990,66(4) :883-890.
-
9Struthers AD. Aldosterone escape during angiotensin- converting enzyme inhibitor therapy in chronic heart failure [J]. J Card Fail, 1996,2(1) ,47-54.
-
10Weber KT. Aldosterone in congestive heart failure[J]. N Engl J Med,2001,345(23) :1689-1697.
二级参考文献8
-
1王昭军,侯建民,任国庆,吴骏,梁仪.凝血功能及血尿酸与急性冠脉综合征临床类型及心功能的关系[J].临床荟萃,2005,20(15):853-855. 被引量:2
-
2李守霞,赵素斌,杨建英,秦冰.冠心病患者血清胆红素、尿酸水平含量及临床价值[J].临床荟萃,2006,21(7):482-483. 被引量:13
-
3Anonymous.Randomized trial of intravenous streptokinase,oral aspirin,both or neither among 17 187 cases of suspected acute myocardial infarction[J].Lancet,1988,2(8607):349-360.
-
4Puddu PE,Lanti M,Menotti A,et al.Serum uric acid for shortterm prediction of cardiovascular disease incidence in the Gubbio population Study[J].Acta Cardiol,2001,56 (4):243-251.
-
5Hoieggen A,Alderman MH,Kjeldsen SE,et al.The impact of serum uric acid on cardiovascular outcomes in the LIFE study[J].Kidney Int,2004,65(3):1041-1049.
-
6Puig JG,Ruilope LM.Uric acid as a cardiovascular risk factor in arterial hypertension[J].J Hypertens,1999,17(7):869-872.
-
7陆丕能,胡大一,陆鋆,王伟民,陈步星.冠心病与血尿酸的关系[J].中华内科杂志,2002,41(8):526-529. 被引量:49
-
8党爱民,刘国仗.尿酸与心血管事件[J].中华心血管病杂志,2003,31(6):478-480. 被引量:244
共引文献3
-
1姜红岩,杨蓉,李拥军,李瑞杰,李莉.替米沙坦和氯沙坦对不稳定型心绞痛患者脂联素的影响[J].临床荟萃,2009,24(5):393-395.
-
2谢培杰.冠心病二级预防的研究进展[J].中华现代护理杂志,2011,17(7):774-776. 被引量:14
-
3李瑾,吴波.血管紧张素转化酶抑制剂治疗冠心病临床疗效观察[J].心血管病防治知识(学术版),2018,8(3):34-36. 被引量:2
-
1张艳丽.代文和洛丁新对充血性心力衰竭血流动力学影响的比较[J].中国中西医结合急救杂志,2005,12(1):21-22. 被引量:1
-
2荆小莉,王东平,宋志红,毕炯.糖尿病大鼠肾组织中核因子-κB的表达及伊贝沙坦防护作用[J].中国医师杂志,2006,8(1):10-12. 被引量:5
-
3申凤俊,朱跃科,贾继东,王宝恩.氯沙坦抗大鼠肝纤维化的研究[J].国外医学(消化系疾病分册),2004,24(6):381-383. 被引量:8
-
4张新军,葛宁,吴锦晖,黄晓丽,张小君,王业钊,章茂顺.血管紧张素Ⅱ受体拮抗剂联合血管紧张素转换酶抑制剂对老年高血压病患者尿蛋白的影响[J].华西医学,2003,18(1):43-45. 被引量:6
-
5赵林双,丁东平,向光大,戚本玲,柯琴梅,乐岭,侯洁,曹红艳.血管紧张素Ⅱ1型受体拮抗剂与醛固酮受体拮抗剂对逆转高血压伴左室扩大患者心肌重塑的作用[J].微循环学杂志,2005,15(1):49-51. 被引量:5
-
6张辉,赵旭兰,郝玉明,王建华,李建华,乔丽敏,谢文丽.急性心肌梗死后不同剂量血管紧张素Ⅱ1型受体拮抗剂早期干预对心功能和神经激素的影响[J].临床荟萃,2005,20(13):724-727. 被引量:1
-
7陶丹.缬沙坦治疗高血压临床疗效观察[J].现代医药卫生,2014,30(21):3296-3297. 被引量:2
-
8陈源源,孙宁玲,王鸿懿,李小鹰,曾容,柯元南,何青,华琦,李瑞杰.氯沙坦治疗对血压达标及左心室舒张功能影响的研究[J].中华老年心脑血管病杂志,2007,9(12):796-799. 被引量:2
-
9黄震华.肾素-血管紧张素系统抑制药和糖尿病[J].中国新药与临床杂志,2011,30(1):11-15. 被引量:3
-
10岑强,杨明,赵燕.缬沙坦对高血压患者左心室肥厚及高敏C反应蛋白的影响[J].中华临床医师杂志(电子版),2010,4(3):77-79. 被引量:11